Vertical transmission of viral infections

Current Opinion in Obstetrics and Gynecology

Volumn 10, Issue 2, 1998, Pages 123-128

  Mandelbrot, Laurent ^a  

^a Serv de Gynecol Obstetrique I ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; HYPERIMMUNE GLOBULIN; LAMIVUDINE; NEVIRAPINE; PLACEBO; VIRUS RNA; ZIDOVUDINE;

BREAST FEEDING; CHICKENPOX; CLINICAL TRIAL; CONGENITAL INFECTION; CYTOMEGALOVIRUS INFECTION; HEPATITIS A; HEPATITIS B; HEPATITIS G VIRUS; HERPES SIMPLEX; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; MATERNAL DISEASE; MOTHER CHILD RELATION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REVIEW; VERTICAL TRANSMISSION; VIRUS INFECTION; WART VIRUS;

CYTOMEGALOVIRUS INFECTIONS; DISEASE TRANSMISSION, VERTICAL; FEMALE; HEPATITIS B; HERPES SIMPLEX; HERPES ZOSTER; HIV INFECTIONS; HUMANS; MATERNAL-FETAL EXCHANGE; PAPILLOMAVIRUS INFECTIONS; PREGNANCY; PRENATAL DIAGNOSIS; VIRUS DISEASES;

EID: 0031953384     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-199804000-00008     Document Type: Review

References (53)

1. Newell ML, Gray G, Bryson YJ. Prevention of mother-to-child HIV-1 infection. AIDS 1997; 11 (Suppl):S165-S172.
2. Connor EM, Sperling RS, Gelber RD, Kiselev P, Scott G, O'Sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994; 331:1173-1180.
3. Cooper ER, Nugent RP, Diaz C, Pitt J, Hanson C, Kalish LA, et al. After AIDS clinical trial 076: the changing pattern of zidovudine use during pregnancy, and the subsequent reduction in the vertical transmission of human immunodeficiency virus in a cohort of infected women and their infants. J Infect Dis 1996; 174:1207-1211.
4. Mayaux MJ, Teglas JP, Mandelbrot L, Berrebi A, Gallais H, Matheron S, et • al. Acceptability and impact of zidovudine prevention on mother-to-child HIV-1 transmission in France. J Pediatr 1997; 131:857-862. One of the studies showing that prophylaxis is effective in clinical practice.
5. Simpson BJ, Shapiro ED, Andiman WA. Reduction in the risk of vertical transmission of HIV-1 associated with treatment of pregnant women with orally administered zidovudine alone. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14:145-152.
6. Gibb DM, MacDonagh SE, Tookey PA, Duons AN, Goldberg DJ, Hudson CN, et al. Uptake of interventions to reduce mother-to-child transmission of HIV in the United Kingdom and Ireland. AIDS 1997: 11:F53-F58.
7. Ekpini ER, Wiktor SZ, Satten GA, Adjorlolo-Johnson GT, Sibailly TS, Ou • CY, et al. Late postnatal mother-to-child transmission of HIV-1 in Abidjan, Côte d'lvoire. Lancet 1997; 349:1054-1059. Estimates of the incidence and timing of transmission through breastfeeding are critical for planning policy and research to decrease vertical HIV transmission in Africa.
8. Bobat R, Moodley D, Coutsoudis A, Coovadia H. Breastfeeding by HIV-1 infected women and outcome in their infants: a cohort study from Durban, South Africa. AIDS 1997; 11:1627-1633.
9. Sperling R, Shapiro DE, Coombs RW, Todd JA, Herman SA, McSherry • GD, et al. for the Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. N Engl J Med 1996; 335:1621-1629. The virological data from the ACTG076/ANRS024 trial offer a unique insight into the mechanism of prevention, as well putting viral load measurements into perspective.
10. Melvin AJ, Burchett SK, Wattz DH, Hughes JP, McLellan CL, King PD, et al. Effect of pregnancy and zidovudine therapy on viral load in HIV-1-infected women. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14:232-236.
11. Aleixo LF, Goodenow MM, Sleasman JW. Zidovudine administered to women infected with human immunodeficiency virus type 1 and to their neonates reduces pediatric infection independent of an effect on levels of maternal virus. J Pediatr 1997; 130:906-914.
12. Mayaux MJ, Dussaix E, Isopet J, Rekacewicz C, Mandelbrot L, Ciraru-Vigneron N, et al. Maternal viral load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohort studies. J Infect Dis 1997; 175:143-148.
13. Thea DM, Steketee RW, Pliner V, Bornschlegel K, Brown T, Orloff S, et al. and the New York City Perinatal HIV transmission collaborative Study Group. The effect of maternal viral load on the risk of perinatal transmission of HIV-1. AIDS 1997; 11:437-444.
14. Cao Y, Krogstad P, Korber BT, Koup RA, Muldoon M, Macken C, et al. and The Ariel Project Investigators. Maternal HIV-1 viral load and vertical transmission of infection: The Ariel Project for the prevention of HIV transmission from mother to infant. Nature Med 1997; 3:549-552.
15. Pitt J, Brambilla D, Reichelderfer P, Landay A, Mcintosh K, Burns D, et al. Maternal immunologic and virologic risk factors for infant human immunodeficiency virus type 1 infection: findings from the women and infants transmission study. J Infect Dis 1997; 175:567-575.
16. Hershow RC, Riester KA, Lew J, Quinn TC, Mofenson LM, Davenny K, et al. for the Women and Infants Transmission Study. Increased vertical transmission of human immunodeficiency virus from hepatitis C virus-coinfected mothers. J Infect Dis 1997; 176:414-420.
17. Hitti J, Watts DH, Burchett SK, Schacker T, Selke S, Brown ZA, Corey L. Herpes simplex virus seropositivity and reactivation at delivery among pregnant women infected with human immunodeficiency virus-1. Am J Obstet Gynecol 1997; 177:450-454.
18. Greenberg BL, Semba RD, Vink PE, Farley JJ, Sivapalasingam M, Steketee RW, et al. Vitamin A deficiency and maternal-infant transmission of HIV in two metropolitan areas in the United States. AIDS 1997; 11:325-332.
19. Burger H, Kovacs A, Weiser B, Grimson R, Nachman S, Tropper P, et al. Maternal serum vitamin A levels are not associated with mother-to-child transmission of HIV-1 in the United States. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14:321-326.
20. Turner BJ, Hauck WW, Fanning TR, Markson LE. Cigarette smoking and maternal-child HIV transmission. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 17:327-337.
21. Burns DN, Landesman S, Wright DJ, Waters D, Mitchell RM, Rubinstein A, et al. Influence of other maternal variables on the relationship between maternal virus load and mother-to-infant transmission of human immunodeficiency virus type 1. J Infect Dis 1997; 175:1206-1210.
22. Loussert-Ajaka I, Mandelbrot L, Delmas MC, Bastian H, Benifla JL, Farfara I, et al. HIV-1 detection in cervicovaginal secretions during pregnancy. AIDS 1997; 11:1575-1581.
23. Wang B, Ge YC, Palasanthiran P, Ziegler J, Bolton W, Xiang SH, et al. HIV type 1 V3 loop sequences derived from peripheral blood of transmitting mothers, their infants, and nontransmitting mothers differ in their crown octapeptide motifs. AIDS Res Hum Retrovirol 1997; 13:275-279.
24. Ugen KE, Srikantan V, Goedert JJ, Nelson RP Jr, Williams WV, Weiner DB. Vertical transmission of human immunodeficiency virus type 1: seroreactivity by maternal antibodies to the carboxy region of the gp41 envelope glycoprotein. J Infect Dis 1997; 175:63-69.
25. Rouzioux C, Costagliola D, Burgard M, Blanche S, Mayaux MJ, Griscelli C, Valleron AJ. Estimated timing of mother-to-child human immunodeficiency virus type 1 transmission by use of a Markov model. Am J Epidemiol 1995; 142:1330-1337.
26. Mandelbrot L. Timing of in utero HIV infection: implications for prenatal diagnosis and management of pregnancy. AIDS Patient Care and STDs 1997; 11:139-148.
27. Kuhn L, Abrams EJ, Matheson PB, Thomas PA, Lambert G, Bamji M, et al. and the New York City Perinatal HIV Transmission Collaborative Study Group. Timing of maternal-infant HIV transmission: associations between intrapartum factors and early polymerase chain reaction results. AIDS 1997; 11:429-435.
28. Mandelbrot L, Brossard Y, Aubin JT, Bignozzi C, Krivine A, Simon F, Dommergues M. Testing for in utero human immunodeficiency virus infection with fetal blood sampling. Am J Obstet Gynecol 175:489-493.
29. Mandelbrot L, Mayaux MJ, Bongain A, Berrebi A, Moudoub-Jeanpetit Y, • Bénifla JL, et al. and the French Pediatric HIV Infection Study Group. Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohorts. Am J Obstet Gynecol 1996; 175:661-667. This is the largest study yet published dealing with obstetrical determinants of HIV transmission.
30. Landesman SH, Kalish LA, Burns DN, Minkoff H, Fox HE, Zorrilla C, et al. for WITS. Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. N Engl J Med 1996; 334:1617-1623.
31. European Collaborative Study. Vertical transmission of HIV-1: maternal • immune status and obstetric factors. AIDS 1996; 10:1575-1681. The largest study to date which observes a lower transmission rate with cesarean versus vaginal delivery.
32. Minkoff H, Augenbraun M. Antiretroviral therapy for pregnant women. Am • J Obstet Gynecol 1997; 176:478-489. This study includes the available preclinical toxicity data on antiretroviral agents and a provocative discussion.
33. Leikin E, Lysikiewicz A, Garry D, Tejani N. Intrauterine transmission of hepatitis A virus. Obstet Gynecol 1996; 88:690-691.
34. Hussaini SH, Skidmore SJ, Richardson P, Sherratt LM, Cooper BT, O'Grady JG. Severe hepatitis E infection during pregnancy. J Viral Hepatol 1997; 4:51-54.
35. Fischler B, Lara C, Chen M, Sönnerborg A, Nemeth A, Sällberg M. Genetic evidence for mother-to-infant transmission of hepatitis G virus. J Infect Dis 1997; 176:281-285.
36. Hunt CM, Carson KL, Sharara AI. Hepatitis C in pregnancy. Obstet • Gynecol 1997; 89:883-890. This study reviews most of the literature on vertical HCV transmission.
37. Ohto H, Terazawa S, Sasaki N, Sasaki N, Hino K, Ishiwata C, et al. Transmission of Hepatitis C virus from mothers to infants. N Engl J Med 1994; 330:744-750.
38. Otigbah C, Kelly A, Aitken C, Norman J, Jeffries D, Erskine KJ. Is HTLV-1 status another antenatal screening test that we need? Br J Obstet Gynaecol 1997; 104:258-260.
39. Ivarsson SA, Lernmark B, Svanberg L. Ten-year clinical, developmental, and intellectual follow-up of children with congenital cytomegalovirus infection without neurologic symptoms at one year of age. Pediatrics 1997; 99:800-803.
40. Hagay ZJ, Biran G, Ornoy A, Reece EA. Congenital cytomegalovirus infection: a long-standing problem still seeking a solution. Am J Obstet Gynecol 1996; 174:241-245.
41. Lipitz S, Yagel S, Shalev E, Achiron R, Mashiach S, Schiff E. Prenatal diagnosis of fetal primary cytomegalovirus infection. Obstet Gynecol 1997; 89:763-767.
42. Hofmeyr GJ, Moolla S, Lawrie T. Prenatal sonographic diagnosis of congenital varicella infection - a case report. Prenatal Diagn 1996; 16:1148-1151.
43. Sauerbrei A, Müller D, Eichhorn U, Wutzler P. Detection of varicella-zoster virus in congenital varicella syndrome: a case report. Obstet Gynecol 1996; 88:687-689.
44. Mouly F, Mirlesse V, Méritet JF, Rozenberg F, Poissonier MH, Lebon P, •• Daffos F. Prenatal diagnosis of fetal varicella-zoster virus infection with polymerase chain reaction of amniotic fluid in 107 cases. Am J Obstet Gynecol 1997; 177:894-898. The largest prospective study of prenatal diagnosis of varicella.
45. Weller TH. Varicella: historical perspective and clinical overview. J Infect Dis 1996; 174 (suppl. 3):S306-S309.
46. Tookey P, Peckham CS. Neonatal herpes simplex virus infection in the British Isles. Paediatr Perinatal Epidemiol 1996; 10:432-442. This is a large, well-conducted survey, which offers information on risk factors for neonatal herpes.
47. Fonnest G, de la Fuente Fonnest I, Weber T. Neonatal herpes in Denmark 1977-1991. Acta Obstet Gynecol Scand 1997; 76:355-358.
48. Kohl S. Neonatal herpes simplex virus infection. Clin Perinatol 1997 24:129-150.
49. Lanouette JM, Duquette DA, Qureshi F, Johnson MP, Berry SM. Prenatal diagnosis of fetal herpes simplex infection. Fetal Diagn Ther 1996; 11:1417-1421.
50. Randolph AG, Hartshorn RM, Washington AE. Acyclovir prophylaxis in • late pregnancy to prevent neonatal herpes: a cost-effectiveness analysis. Obstet Gynecol 1996; 88:603-610. A well-documented critique of the policy of cesarean sections for the prevention of neonatal herpes which makes a good case for acyclovir prophylaxis.
51. Boggess K, Watts H, Hobson AC, Ashley RL, Brown ZA, Corey L. Herpes simplex virus type 2 detection by culture and polymerase chain reaction and relationship to genital symptoms and cervical antibody status during the third trimester of pregnancy. Am J Obstet Gynecol 1997; 176:443-451.
52. Puranen MH, Yliskoski MH, Saarikoski SV, Srjänen KJ, Syrjänen SM. Exposure of an infant to cervical human papillomavirus infection of the mother is common. Am J Obstet Gynecol 1997; 176:1039-1045.
53. Levy R, Weissman A, Blomberg G, Hagay ZJ. Infection by parvovirus B 19 during pregnancy: a review. Obstet Gynecol Survey 1997; 52:254-259.